Targeted agents vs. chemoimmunotherapy as first-line treatment of CLLOctober 3, 2019Lymphoma & Plasma Cell DisordersLeukemia, Myelodysplasia, TransplantationHematology
Stem cells gene edited to be HIV resistant treat ALL, but not HIVSeptember 11, 2019Leukemia, Myelodysplasia, TransplantationHematology
Hematocrit (HCT) Levels and Thrombotic Events Among US Veterans With Polycythemia VeraSeptember 9, 2019Hematology
Abstracts Presented at the 2019 AVAHO Annual Meeting (Digital Edition)September 9, 2019HematologyOncology
Standardization of the Discharge Process for Inpatient Hematology and OncologySeptember 6, 2019Hematology
Investigation of Outpatient Infusion Space Utilization to Increase Access to Same-Day Transfusion for Hematology/Oncology PatientsSeptember 5, 2019Hematology
Use of Biosimilar Granulocyte Colony-Stimulating Factor for Mobilization in Autologous and Allogeneic Hematopoietic Stem Cell Transplantation in a Veteran PopulationSeptember 5, 2019Hematology
Ibrutinib-rituximab induction yields ‘unprecedented’ responses in MCLAugust 27, 2019Lymphoma & Plasma Cell DisordersHematology
Fatal Drug-Resistant Invasive Pulmonary Aspergillus fumigatus in a 56-Year-Old Immunosuppressed Man (FULL)August 14, 2019HematologyHospice & Palliative Medicine
BRCA2 mutations linked to childhood NHLJuly 25, 2019HematologyOncologyLymphoma & Plasma Cell Disorders
Ibrutinib-venetoclax found highly active in hard-to-treat CLLJuly 22, 2019Leukemia, Myelodysplasia, TransplantationHematology
SC daratumumab deemed feasible for every multiple myeloma patientJuly 11, 2019Multiple MyelomaLymphoma & Plasma Cell DisordersHematology
